| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 阳景 | 浦银国际证券 | 医药生物 | 27.97% | 34.07% | 27.97% | 100.00% | 2 | 0.00% | 2025-03-31 |
| 2 | 张林晚 | 上海证券 | 医药生物 | 27.92% | 16.71% | 24.66% | -100.00% | 1 | -18.93% | 2025-06-04 |
| 3 | 张林晚 | 上海证券 | 医药生物 | 27.92% | 15.33% | 22.77% | -100.00% | 1 | -18.93% | 2025-06-10 |
| 4 | 唐寅灏 | 中信证券 | 医药生物 | 27.89% | 17.78% | 30.16% | 85.71% | 6 | -8.47% | 2025-05-09 |
| 5 | 阳景 | 浦银国际证券 | 医药生物 | 27.87% | 33.87% | 9.87% | 100.00% | 4 | 0.00% | 2025-05-20 |
| 6 | 仰佳佳 | 申万宏源 | 医药生物 | 27.86% | 35.86% | 21.74% | 23.08% | 1 | -37.64% | 2025-05-23 |
| 7 | 袁聪敏 | 中信证券 | 医药生物 | 27.79% | 21.62% | 25.25% | 100.00% | 5 | 0.00% | 2025-04-16 |
| 8 | 华挺 | 财通证券 | 医药生物 | 27.68% | 22.12% | 14.60% | -6.67% | 4 | -50.33% | 2025-06-06 |
| 9 | 武煜 | 招银国际 | 医药生物 | 27.65% | 25.18% | 21.51% | -33.33% | 2 | -16.66% | 2025-05-16 |
| 10 | 唐寅灏 | 中信证券 | 医药生物 | 27.61% | 22.73% | 31.06% | 85.71% | 6 | -8.47% | 2025-04-30 |
| 11 | 王斌 | 首创证券 | 医药生物 | 27.60% | 32.26% | 20.60% | 4.11% | 20 | -54.62% | 2025-07-16 |
| 12 | 仰佳佳 | 申万宏源 | 医药生物 | 27.59% | 35.42% | 27.66% | 23.08% | 1 | -37.64% | 2025-05-16 |
| 13 | 周豫 | 太平洋 | 医药生物 | 27.57% | 19.64% | 16.53% | 21.21% | 23 | -55.62% | 2025-06-10 |
| 14 | 武煜 | 招银国际 | 医药生物 | 27.57% | 25.11% | 21.44% | -33.33% | 2 | -16.66% | 2025-05-15 |
| 15 | 武煜 | 招银国际 | 医药生物 | 27.55% | 20.19% | 21.42% | -33.33% | 2 | -16.66% | 2025-05-14 |
| 16 | 刘浩 | 华创证券 | 医药生物 | 27.54% | 39.08% | 25.99% | 29.41% | 1 | -47.33% | 2025-03-27 |
| 17 | 张林晚 | 上海证券 | 医药生物 | 27.54% | 14.79% | 21.53% | -100.00% | 1 | -18.93% | 2025-06-11 |
| 18 | 马云涛 | 国元证券 | 医药生物 | 27.53% | 34.91% | 19.63% | -17.65% | 1 | -47.07% | 2025-07-16 |
| 19 | 华挺 | 财通证券 | 医药生物 | 27.53% | 21.09% | 19.85% | -6.67% | 4 | -50.33% | 2025-06-03 |
| 20 | 武煜 | 招银国际 | 医药生物 | 27.51% | 24.41% | 18.95% | -33.33% | 2 | -16.66% | 2025-05-19 |